That's the sound of a cell cycle clock - the molecular metronome that tells your cells when to divide. For most cells, it's a well-regulated symphony. But in the breast tissue of women under 40 with estrogen receptor-positive (ER+) cancer, that clock has apparently decided to go rogue, and it...
Cooking competitions, spelling bees, hot dog eating contests - all perfectly normal things to hold a bakeoff for. But biomarkers? Leave it to the Pancreatic Cancer Detection Consortium to turn the search for early cancer detection into a legitimate throwdown.
Twenty-four protein subunits. One hollow cage. That's all ferritin is - a tiny, self-assembling sphere your body already makes by the billions to store iron. Now multiply that simplicity by the sheer stubbornness of leukemia, where over 50% of patients relapse after CAR T cell therapy, and you've...
Think of your average city bus route: a driver, some passengers, a schedule that mostly works. Now imagine the bus driver is actively sabotaging the route, the passengers are building illegal extensions to the road, and somehow the whole operation keeps expanding despite transit authorities...
Thirty trillion. That's roughly how many cells make up your body, and every single one of them knows its place and job. Except, of course, when cancer crashes the party and starts rewriting the rulebook.
Somewhere between your morning coffee and your lunch break today, about 400 people worldwide heard the words "metastatic colorectal cancer." And for a big chunk of those people, their first round of chemotherapy has already stopped working - which is a bit like discovering your car's brakes failed...
The forecast inside a small cell lung cancer tumor looks grim today: thick clouds of drug-resistant signaling, a persistent high-pressure system of rogue kinases, and absolutely zero chance of chemotherapy getting through. Overnight temperatures in the tumor microenvironment have dropped to...
If CD19-targeted CAR T cells had an Instagram, their bio would read: "First FDA-approved gene therapy 💉 | Pediatric cancer fighter since 2017 | 90% remission rate energy | Currently beefing with solid tumors 😤 | DMs open for B-ALL referrals only." And honestly? That profile would be verified.
For years, oncologists operated under a tidy assumption: HER2-positive breast cancer and hormone receptor-positive breast cancer were essentially separate problems requiring separate playbooks. Target HER2 with trastuzumab and pertuzumab, treat HR+ disease with endocrine therapy and CDK4/6...
That's basically what follicular lymphoma cells are - B cells that forgot how to die. Your immune system normally runs a pretty tight ship when it comes to retiring old or broken cells, but follicular lymphoma cells carry a genetic cheat code (a translocation called t(14;18), if you want to impress...
Radiation therapy is not just a blunt instrument that fries tumors. There, I said it. For decades, oncologists treated radiation like a sledgehammer - point it at the cancer, crank up the dose, and hope for the best. But a sweeping new review in Nature Reviews Cancer argues that we've been so...
The villain wasn't hiding in the shadows—it was already inside the house, pretending to be furniture.
Most people assume that once you've exhausted two lines of chemotherapy for metastatic colorectal cancer, your remaining options are basically a choice between "meh" and "slightly worse than meh." Turns out, they might be wrong.
Hey there, you sneaky little DNA fragment. Yes, you - the circulating tumor DNA floating around in someone's bloodstream right now, thinking you're invisible. You've been slipping past detection for years, hiding in a sea of normal cell-free DNA like a spy in a crowded marketplace. But scientists...
Tomorrow morning, a woman with metastatic ER-positive breast cancer will learn her tumors have stopped responding to chemotherapy. Her oncologist will flip through the limited options remaining, searching for something - anything - that might buy more time. What if the answer has been sitting in...
Forty percent. That's roughly the local recurrence rate for colorectal cancer patients who receive radiotherapy. You'd think blasting tumors with radiation would be enough to rally the immune system into action, but cancer cells have been running a surprisingly sophisticated sabotage operation...
Pulmonary sarcomatoid carcinoma and a Marvel villain have more in common than you'd think. Both are rare, both are terrifyingly aggressive, and both seem designed to make heroes' lives miserable. But unlike the Avengers, oncologists fighting PSC have been working without a decent playbook—until now.
Like the mystery of why socks vanish in the dryer or how Amelia Earhart disappeared over the Pacific, there's been a baffling puzzle haunting American healthcare: we have a screening test that can catch lung cancer early and cut deaths by 20%, yet barely anyone actually gets it. We're talking about...
Your immune system has been doing reps for years, but it took a little pharmaceutical personal training to really see results. Think of the HPV vaccine as the world's most effective workout plan for your immune cells - and the gains are finally showing up in the data.
Glioblastoma doesn't just grow. It builds an entire ecosystem around itself - what scientists call the tumor microenvironment. Think of it as the tumor's personal support staff: blood vessels delivering supplies, immune cells that should be fighting but have been convinced to stand down, and a...